FZMD OTC
Fuse Medical, Inc.
1W: +65.0%
1M: +17.9%
3M: +65.0%
YTD: +65.0%
1Y: -45.0%
3Y: -78.0%
5Y: -74.6%
$0.03
+0.01 (+43.48%)
Weekly Expected Move ±36.0%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$11M
-33.4% ▼
5Y CAGR: -14.1%
Gross Profit
$7M
-36.0% ▼
5Y CAGR: -9.2%
Operating Income
$721K
+88.0% ▲
Net Income
$514K
-64.8% ▼
EPS (Diluted)
$0.01
-64.9% ▼
EBITDA
$881K
-52.0% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $21M | $20M | $19M | $16M | $11M |
| YoY Growth | -6.6% | -4.6% | -8.7% | -13.6% | -33.4% |
| Cost of Revenue | $9M | $8M | $7M | $5M | $4M |
| Gross Profit | $13M | $12M | $12M | $11M | $7M |
| Gross Margin | 59.4% | 58.5% | 61.9% | 66.6% | 64.0% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $14M | $14M | $12M | $10M | $6M |
| Operating Expenses | $14M | $14M | $12M | $10M | $6M |
| Operating Income | -$1M | -$2M | -$815K | $384K | $721K |
| Operating Margin | -4.8% | -10.8% | -4.4% | 2.4% | 6.7% |
| Interest Expense | $95K | $78K | $171K | $221K | $192K |
| Income Before Tax | -$1M | -$2M | $3M | $1M | $530K |
| Tax Expense | $19K | $18K | $24K | $23K | $16K |
| Net Income | -$1M | -$2M | $3M | $1M | $514K |
| Net Margin | -6.7% | -7.8% | 16.6% | 9.1% | 4.8% |
| EPS (Diluted) | $-0.02 | $-0.02 | $0.04 | $0.02 | $0.01 |
| EBITDA | -$1M | -$1M | $3M | $2M | $881K |
| Shares Outstanding | 70M | 70M | 78M | 78M | 78M |